Vaccine delivery systems based on amphiphilic bioresorbable polymers and their role in vaccine immunogenicity

Immunogenicity

Volumn , Issue , 2011, Pages 67-90

  Huang, Ming Hsi ^a   Leng, Chih Hsiang ^a   Liu, Shih Jen ^a   Chen, Hsin Wei ^a   Sia, Charles ^a   Chong, Pele ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Antigen sparing; Bioresorbable polymer; Emulsion; Immunobioengineering; Vaccine adjuvant

Indexed keywords

EID: 84879101557     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (42)

1. Stohr, K. Vaccinate before the next pandemic? Nature, 2010, 465(7295), 161-161.
2. Schubert, C. Boosting our best shot. Nat Med, 2009, 15(9), 984-988.
3. Check, E. Avian flu special Is this our best shot? Nature, 2005, 435(7041), 404-406.
4. Bresson, JL; Perronne, C; Launay, O; Gerdil, C; Saville, M; Wood, J; Höschler, K; Zambon, MC. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet, 2006, 367(9523), 1657-1664.
5. Singh, M; O'Hagan, D. Advances in vaccine adjuvants. Nat Biotech, 1999, 17(11), 1075-1081.
6. Marciani, DJ. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today, 2003, 8(20), 934-943.
7. O'Hagan, DT; De Gregorio, E. The path to a successful vaccine adjuvant - The long and winding road. Drug Discov Today, 2009, 14(11-12), 541-551.
8. Satoh, M; Kuroda, Y; Yoshida, H; Behney, KM; Mizutani, A; Akaogi, J; Nacionales, DC; Lorenson, TD; Rosenbauer, RJ; Reeves, WH. Induction of lupus autoantibodies by adjuvants. J Autoimmun, 2003, 21(1), 1-9.
9. Hubbell, JA; Thomas, SN; Swartz, MA. Materials engineering for immunomodulation. Nature, 2009, 462(7272), 449-460.
10. Reddy, ST; Swartz, MA; Hubbell, JA. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol, 2006, 27(12), 573-579.
11. Guy, B. The perfect mix: recent progress in adjuvant research. Nat Rev Micro, 2007, 5(7), 505-517.
12. McKee, AS; Munks, MW; Marrack, P. How Do Adjuvants Work? Important Considerations for New Generation Adjuvants. Immunity, 2007, 27(5), 687-690.
13. Aucouturier, J; Dupuis, L; Ganne, V. Adjuvants designed for veterinary and human vaccines. Vaccine, 2001, 19(17-19), 2666-2672.
14. Huang, MH; Huang, CY; Lien, SP; Siao, SY; Chou, AH; Chen, HW; Liu, SJ; Leng, CH; Chong, P. Development of multi-phase emulsions based on bioresorbable polymers and oily adjuvant. Pharm Res., 2009, 26(8), 1856-1862.
15. Huang, MH; Chou, AH; Lien, SP; Chen, HW; Huang, CY; Chen, WW; Chong, P; Liu, SJ; Leng, CH. Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-ε-caprolactone). J Biomed Mater Res B, Appl Biomater, 2009, 90B(2), 832-841.
16. Siao, SY; Lin, LH; Chen, WW; Huang, MH; Chong, P. Characterization and emulsifying properties of block copolymers prepared from lactic acid and poly(ethylene glycol). J Appl Polym Sci., 2009, 114(1), 509-516.
17. Huang, MH; Huang, CY; Lin, SC; Chen, JH; Ku, CC; Chou, AH; Liu, SJ; Chen, HW; Chong, P; Leng, CH. Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine. Microbes Infect, 2009, 11(6-7), 654-660.
18. Langer, R. New methods of drug delivery. Science, 1990, 249(4976), 1527-1533.
19. Li, S; Vert, M. Biodegradable polymers: Polyesters. In: E. Mathiowitz, editor. The encyclopedia of controlled drug delivery. New York: Wiley, 1999, 71-93.
20. Newman, MJ; Balusubramanian, M; Todd, CW. Development of adjuvant-active nonionic block copolymers. Adv Drug Deliv Rev., 1998, 32(3), 199-223.
21. Bromberg, LE; Ron, ES. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev., 1998, 31(3), 197-221.
22. Jeong, B; Bae, YH; Lee, DS; Kim, SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature, 1997, 388(6645), 860-862.
23. Hwang, MJ; Suh, JM; Bae, YH; Kim, SW; Jeong, B. Caprolactonic Poloxamer analog: PEG-PCL-PEG. Biomacromolecules, 2005, 6(2), 885-890.
24. Discher, DE; Ortiz, V; Srinivas, G; Klein, ML; Kim, Y; Christian, D; Cai, S; Photos, P; Ahmed, F. Emerging applications of polymersomes in delivery: From molecular dynamics to shrinkage of tumors. Prog Polym Sci., 2007, 32(8-9), 838-857.
25. Landreau, E; Aguni, Y; Hamaide, T; Chevalier, Y. Preparation of nanoemulsions by spontaneous emulsification and stabilization with poly(caprolactone)-b-poly(ethylene oxide) block copolymers. In: Tadros TF, editor. Emulsion Science and Technology, Weinheim: Wiley-Vch, 2009, 191-207.
26. Hutmacher, DW. Polymeric scaffolds in tissue engineering bone and cartilage. Biomaterials, 2000, 21, 2529-2543.
27. Youan, BBC; Jackson, TL; Dickens, L; Hernandez, C; Owusu-Ababioa, G. Protein release profiles and morphology of biodegradable microcapsules containing an oily core. J Control Release, 2001, 76, 313-326.
28. Kasperczyk, J; Li, S; Jaworska, J; Dobrzynski, P; Vert, M. Degradation of copolymers obtained by ring-opening polymerization of glycolide and ε-caprolactone: A high resolution NMR and ESI-MS study. Polym Degrad Stab., 2008, 93(5), 990-999.
29. Li, SM; Espartero, JL; Foch, P; Vert, M. Structural characterization and hydrolytic degradation of a Zn metal initiated copolymer of L-lactide and ε-caprolactone. J Biomater Sci Polym Ed, 1996, 8(3), 165-87.
30. Huang, MH; Li, S; Coudane, J; Vert, M. Synthesis and characterization of block copolymers of ε-caprolactone and DL-lactide Initiated by ethylene glycol or poly(ethylene glycol). Macromol Chem and Phys., 2003, 204(16), 1994-2001.
31. Cerrai, P; Cristallini, C; Del Chicca, M; Guerra, G; Maltinti, S; Guerra, R; Tricoli, M. Hydrolysis of poly(ester-ether-ester) block copolymers in the presence of endothelial cells: in vitro modulation of endothelin release. Polym Bull, 1997, 39(1), 53-58.
32. Cuong, NV; Hsieh, MF; Chen, YT; Liau, I. Synthesis and characterization of PEG-PCL-PEG triblock copolymers as carriers of doxorubicin for the treatment of breast cancer. J Appl Polym Sci., 2010, 117(6), 3694-3703.
33. Lee, H; Chang, T; Lee, D; Shim, MS; Ji, H; Nonidez, WK; Mays, JW. Characterization of poly(L-lactide)-block-poly(ethylene oxide)-block-poly(L-lactide) triblock copolymer by liquid chromatography at the critical condition and by MALDI-TOF mass spectrometry. Anal Chem., 2001, 73(8), 1726-32.
34. Vogel, FR; Powell, MF. A compendium of vaccine adjuvants and excipients. In: MF; Powell, MJ. Newman, editors. Vaccine design: the subunit and adjuvant approach. New York: Plenum, 1995, 141-228.
35. Chang, JCC; Diveley, JP; Savary, JR; Jensen, FC. Adjuvant activity of incomplete Freund's adjuvant. Adv Drug Del Rev., 1998, 32, 173-86.
36. Aucouturier, J; Dupuis, L; Deville, S; Ascarateil, S; Ganne, V. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev Vaccines, 2002, 1, 111-8.
37. Mosca, F; Tritto, E; Muzzi, A; Monaci, E; Bagnoli, F; Iavarone, C; O'Hagan, D; Rappuoli, R; De Gregorio, E. Molecular and cellular signatures of human vaccine adjuvants. Proc Natl Acad Sci USA, 2008, 105, 10501-10506.
38. Leroux-Roels, I; Borkowski, A; Vanwolleghem, T; Dramé, M; Clement, F; Hons, E; Devaster, JM; Leroux-Roels, G. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet, 2007, 370, 580-589.
39. van Zuylen, L; Verweij, J; Sparreboom, A. Role of formulation vehicles in taxane pharmacology. Invest New Drugs, 2001, 19, 125-141.
40. Gaucher, G; Poreba, M; Ravenelle, F; Leroux, JC. Poly(N-vinylpyrrolidone)- block-poly(D,L-lactide) as polymeric emulsifier for the preparation of biodegradable nanoparticles. J Pharm Sci., 2007, 96, 1763-1775.
41. Umbreit, JN; Strominger, JL. Relation of detergent HLB number to solubilization and stabilization of D-Alanine carboxypeptidase from Bacillus subtilis membranes. Proc Natl Acad Sci USA, 1973, 70, 2997-3001.
42. Huang, MH; Li, S; Hutmacher, DW; Schantz, JT; Vacanti, CA; Braud, C; Vert, M. Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of ε-caprolactone in the presence of poly(ethylene glycol). J Biomed Mater Res A, 2004, 69A(3), 417-427.